Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ)
CNY 10.64
(0.09%)
CNY 10.64
(0.09%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.12 Billion | 4.37 Billion | 4.33 Billion | 4.01 Billion | 3.7 Billion | 3.62 Billion |
| Cost of Revenue | 1.97 Billion | 1.83 Billion | 1.81 Billion | 1.78 Billion | 1.46 Billion | 1.48 Billion |
| Gross Profit | 2.15 Billion | 2.54 Billion | 2.52 Billion | 2.23 Billion | 2.24 Billion | 2.13 Billion |
| Operating Expenses | 1.53 Billion | 1.79 Billion | 1.8 Billion | 1.55 Billion | 1.61 Billion | 1.61 Billion |
| Selling, General and Administrative Expenses | 1.22 Billion | 1.35 Billion | 1.38 Billion | 1.17 Billion | 1.22 Billion | 1.29 Billion |
| Research and Development Expenses | 253.49 Million | 266.76 Million | 243.37 Million | 208.38 Million | 204.52 Million | 142.85 Million |
| Other Expenses | - | 169.86 Million | 178.29 Million | 165 Million | 182.79 Million | -862.38 Thousand |
| Cost and Expenses | 3.49 Billion | 3.62 Billion | 3.61 Billion | 3.33 Billion | 3.07 Billion | 3.09 Billion |
| Operating Income | 646.45 Million | 878.59 Million | 754.67 Million | 597.23 Million | 543.39 Million | 431.24 Million |
| Interest Expense | 6.64 Million | 6.28 Million | 23.1 Million | 49.23 Million | 59.83 Million | 66.38 Million |
| Income Tax Expense | 79.56 Million | 124.5 Million | 108 Million | 92.24 Million | 84.81 Million | 85.01 Million |
| Earnings before Tax | 641.68 Million | 871.89 Million | 725.88 Million | 621.24 Million | 527.29 Million | 430.38 Million |
| Net Income | 563.08 Million | 749.41 Million | 619.32 Million | 504.5 Million | 410.36 Million | 301.36 Million |
| Earnings Per Share Basic | 0.57 | 0.76 | 0.63 | 0.51 | 0.45 | 0.33 |
| Earnings Per Share Diluted | 0.57 | 0.76 | 0.63 | 0.51 | 0.45 | 0.33 |
| Weighted Average Shares Outstanding | 987.86 Million | 989.2 Million | 989.2 Million | 989.2 Million | 916.21 Million | 913.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 987.86 Million | 989.2 Million | 989.2 Million | 989.2 Million | 916.21 Million | 913.22 Million |
| Gross Margin | 0.52 | 0.58 | 0.58 | 0.56 | 0.61 | 0.59 |
| EBIT Margin | 0.21 | 0.23 | 0.22 | 0.21 | 0.21 | 0.18 |
| Profit Margin | 0.14 | 0.17 | 0.14 | 0.13 | 0.11 | 0.08 |
| EBITDA | 863.95 Million | 1.02 Billion | 946.88 Million | 865.85 Million | 744.44 Million | 645.81 Million |
| Earnings Before Tax Margin | 0.16 | 0.20 | 0.17 | 0.15 | 0.15 | 0.12 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.09 Billion | 1.08 Billion | 1.03 Billion | 874.03 Million | 4.08 Billion | 1.11 Billion |
| Cost of Revenue | 503.19 Million | 515.73 Million | 465.93 Million | 375.86 Million | 1.99 Billion | 554.85 Million |
| Gross Profit | 595.96 Million | 573.15 Million | 566.4 Million | 498.17 Million | 2.09 Billion | 564.48 Million |
| Operating Expenses | 366.57 Million | 372.38 Million | 412.68 Million | 411.6 Million | 1.49 Billion | 390.62 Million |
| Selling, General and Administrative Expenses | 508.73 Million | 294.62 Million | 344.17 Million | 291.46 Million | - | 439.27 Million |
| Research and Development Expenses | 59.77 Million | 53.54 Million | 68.5 Million | 119.08 Million | - | 46.06 Million |
| Other Expenses | -201.93 Million | -24.22 Million | -1.84 Million | -1.06 Million | -20.76 Million | 147.33 Thousand |
| Cost and Expenses | 869.76 Million | 888.12 Million | 878.61 Million | 787.47 Million | 3.49 Billion | 945.48 Million |
| Operating Income | 221.36 Million | 200.76 Million | 153.72 Million | 86.56 Million | 595.49 Million | 191.58 Million |
| Interest Expense | 449.21 Thousand | 341.54 Thousand | 596.18 Thousand | 794.14 Thousand | 3.36 Million | 823.61 Thousand |
| Income Tax Expense | 25.56 Million | 33.83 Million | 25.61 Million | 8.22 Million | 79.56 Million | 20.74 Million |
| Earnings before Tax | 220.58 Million | 225.77 Million | 177.13 Million | 117.73 Million | 649.63 Million | 191.72 Million |
| Net Income | 190.45 Million | 188.6 Million | 151.12 Million | 91.48 Million | 563.08 Million | 169.79 Million |
| Earnings Per Share Basic | 0.19 | 0.19 | 0.15 | 0.09 | - | 0.17 |
| Earnings Per Share Diluted | 0.19 | 0.19 | 0.15 | 0.09 | - | 0.17 |
| Weighted Average Shares Outstanding | 989.2 Million | 989.2 Million | 989.2 Million | 989.2 Million | 989.2 Million | 989.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 989.2 Million | 989.2 Million | 989.2 Million | 989.2 Million | 989.2 Million | 989.2 Million |
| Gross Margin | 0.54 | 0.53 | 0.55 | 0.57 | 0.51 | 0.50 |
| EBIT Margin | 0.20 | 0.23 | 0.18 | 0.17 | - | 0.17 |
| Profit Margin | 0.17 | 0.17 | 0.15 | 0.10 | 0.14 | 0.15 |
| EBITDA | 221.03 Million | 253.8 Million | 188.65 Million | 144.67 Million | - | 187.84 Million |
| Earnings Before Tax Margin | 0.20 | 0.18 | 0.15 | 0.10 | 0.15 | 0.17 |
3122
450080
0547
6986
NTST
6224